Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

In search of biomarkers for leprosy by unraveling the host immune response to Mycobacterium leprae.

van Hooij A, Geluk A. Immunological reviews. 2021;
Download PDF
Publication

Comparison of IL-17 and FOXP3+ Levels in Maternal and Children Leprosy Patients in Endemic and Nonendemic Areas.

Prakoeswa F, Maharani F, Fitriah M, et al. Interdisciplinary perspectives on infectious diseases. 2021;
Download PDF
Publication

Leprosy post-exposure prophylaxis risks not adequately assessed

Lockwood DNJ, De Barros B, Negera E, et al. Elsevier BV. The Lancet Global Health. 2021; 9 (4) : e400-e401.
Download PDF
Publication

Leprosy post-exposure prophylaxis risks not adequately assessed – Author's reply

Richardus JH, Mieras L, Saunderson P, et al. Elsevier BV. The Lancet Global Health. 2021; 9 (4) : e402-e403.
Download PDF
Publication

Highlights of the Pre Congress Workshop No. 7 January 29th and 30th 2008; International Leprosy Congress, 2008 Hyderabad, India

Sundar Rao PSS, Chandna R. Lepra. Leprosy Review. 2008; 79 (2) : 223-229.
Download PDF
Publication

John Leslie Turk, MD, DSc, FRCP, FRCS, FRCPath (1930–2006)

Allen I. Lepra. Leprosy Review. 2007; 78 (4) : 409-413.
Download PDF
Publication

INDEPENDENT EVALUATION OF GAEL

Daumerie D. Lepra. Leprosy Review. 2004; 75 (4) : 407-408.
Download PDF
Publication

A STRATEGY TO IMPROVE THE ML FLOW TEST FOR DETECTION OF ANTI-PHENOLIC GLYCOLIPID-1 ANTIBODIES: REPLY

Oskam L, Bührer-Sékula S. Lepra. Leprosy Review. 2004; 75 (2) : 194-195.
Download PDF
Publication

REPLY TO LETTER BY SUBMITTED BY DUTCH NEUROPATHIC FOOT SOCIETY

Wim Brandsma J, Macdonald M. Lepra. Leprosy Review. 2003; 74 (1) : 86-86.
Download PDF
Publication

SOCIO-ECONOMIC REHABILITATION IN LEPROSY—AN EXAMPLE

Joseph Kawuma H. Lepra. Leprosy Review. 2003; 74 (1) : 83-83.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 285
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD